Drug Shortage Report for TELMISARTAN HCTZ
| Report ID | 76655 |
| Drug Identification Number | 02390310 |
| Brand name | TELMISARTAN HCTZ |
| Common or Proper name | TELMISARTAN HCTZ |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
| Strength(s) | 25.0MG 80.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-04-08 |
| Actual start date | |
| Estimated end date | 2019-04-19 |
| Actual end date | 2019-03-11 |
| Shortage status | Avoided shortage |
| Updated date | 2019-03-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-03-11 | French | Compare |
| v5 | 2019-03-11 | English | Compare |
| v4 | 2019-03-04 | French | Compare |
| v3 | 2019-03-04 | English | Compare |
| v2 | 2019-02-22 | French | Compare |
| v1 | 2019-02-22 | English | Compare |
Showing 1 to 6 of 6